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Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles
and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern
Province, Zambia
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Abstract. Age-speciﬁc population immunity to many vaccine-preventable diseases can be measured using serological surveys. However, stand-alone serological surveys are infrequently conducted in low- and middle-income
countries because of costs, operational challenges, and potential high refusal rates for blood collection. Nesting a
serosurvey within a household cluster survey may overcome some of these challenges. We share lessons learned from
nesting a serosurvey within a measles and rubella vaccination post-campaign coverage evaluation survey (PCES). In 15 of
the 26 PCES clusters in Southern Province, Zambia, we collected dried blood spots from 581 participants aged 9 months
and older. Household participation rates for the main PCES were higher in the serosurvey clusters (86%) than PCES-only
clusters (71%), suggesting that a serosurvey can be successfully integrated without adversely affecting PCES participation. Among households that participated in the PCES, 80% also participated in the serosurvey and 86% of individuals
available in the household provided a blood sample for the serosurvey. Substantial planning and coordination, additional
staff training, and community mobilization were critical to the success of the serosurvey. Most challenges stemmed from
using different data collecting tools and teams for the serosurvey and PCES. A more efﬁcient design would be to fully
integrate the serosurvey by adding blood collection and additional questions to the PCES.

The national catch-up MR vaccination campaign was conducted in Zambia from September 19 to 24, 2016. The campaign targeted children aged 9 months to 15 years, and it was
the ﬁrst time a rubella-containing vaccine was administered
nationally in Zambia. Two months after the MR campaign,
the Ministry of Health (MoH) commissioned a PCES, a nationwide household cluster survey aimed at measuring
vaccination coverage achieved by the campaign and routine
vaccination.10 Data collection for the PCES was conducted
between November 21 and December 3, 2016. The PCES
used a two-stage cluster survey design adapted from the
WHO Vaccination Coverage Cluster Survey Manual to select
30 clusters per province with probability of cluster selection
proportional to estimated size and 12 households per
cluster.11
To measure age-speciﬁc population immunity to MR viruses, the serosurvey team partnered with the PCES team to
conduct a serological survey using dried blood spots (DBS) in
Southern Province, Zambia. Although the PCES was conducted throughout the country, the nested serosurvey was
conducted only in the Southern Province to leverage access to
a laboratory with storage facilities and expertise in serology.
Measles and rubella were the primary antigens of interest for
both the PCES and serosurvey, but the target age ranges
differed. The PCES focused on children eligible for the vaccination campaign but the serosurvey aimed to evaluate
population immunity among children aged 9 months and older
as well as adults, including rubella immunity among women of
childbearing age. The sampling strategy for the serosurvey
was based on the design of the PCES and aimed to estimate
seroprevalence with a precision of ±5%. We assumed a 36%
nonparticipation rate for blood collection based on a previous
serosurvey.12,13
For logistical reasons, the serosurvey was conducted in a
random sample of 15 PCES clusters in the Southern Province.

Age-speciﬁc population immunity, measured as the proportion of individuals across age strata with protective levels of
antigen-speciﬁc immunoglobulin G antibodies, can be estimated using serological surveys for many vaccine-preventable
diseases (VPDs).1 However, serosurveys are infrequently conducted in low- and middle-income countries because of cost,
operational challenges to blood collection, transport and processing of samples, and concerns about participant refusal rates
for blood collection.2–5 Instead, speciﬁc population immunity is
commonly inferred from vaccination coverage estimates, which
may be inaccurate and do not reﬂect true population immunity
because of primary and secondary vaccine failure and exposure
to natural infection.2,5,6 Rigorously designed serosurveys directly
measure population susceptibility and immunity and can be
used to assess the proportion of children protected after a vaccination campaign.1 Knowledge of age-speciﬁc immunity proﬁles, spatial clustering, and susceptibility among subpopulations
can guide targeted vaccination activities and improve the efﬁciency of immunization programs.7,8
For serological surveillance of VPDs to be practical and
sustainable, serosurveys should ideally be conducted within
existing surveillance systems or multipurpose household
surveys, such as Demographic and Health Surveys or Multiple
Indicator Cluster Surveys, nationally representative surveys
for malaria or human immunodeﬁciency virus infection, or
post-campaign coverage evaluation surveys (PCES).9 We
nested a serological survey within a PCES in one province of
southern Zambia following a national measles and rubella
(MR) vaccination campaign. We describe the processes that
enabled successful implementation of the nested serosurvey
and highlight the challenges and lessons learned.
* Address correspondence to Simon Mutembo, 114 B.S. Miller Hall,
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Overall, 249 of the 312 eligible households were enrolled in
the PCES survey in the Southern Province (Figure 1). The
serosurvey did not appear to impact household participation in the PCES as 71% of households in the PCES-only
clusters participated, compared with 86% of households
in the PCES plus serosurvey clusters. For the serosurvey,
124 (80%) PCES households were enrolled over 12 days. Of
those households that did not participate in the serosurvey,
8% were not available and 12% refused. Reasons for refusal
were different among households but were mostly because of
nonavailability of the head of the household at the time of the
serosurvey. One cluster, which represented 12 households,
refused to take part in both the PCES and the serosurvey
because the community was suspicious that personal information and blood would be used for satanic religious purposes. Combining the PCES and serosurvey participation
rates, 69% of households eligible in the PCES sampling frame
were included in the serosurvey.
Within the 124 households that agreed to participate in the
serosurvey, 830 individuals were eligible and 675 (81%) of
them were available at the time of the serosurvey. Of the
available individuals, 581 (86%) participated and provided a
blood sample, 11% refused, 2% did not have caregiver
available to provide consent, and 1% were ineligible for other
reasons.

Planning and coordination were required at all levels and
throughout each stage of the survey. A technical coordination
group comprising MoH ofﬁcials, WHO Zambia ofﬁcials, and
PCES implementing partners worked with the serosurvey
planning team for 3 months before the PCES to develop
a coordination plan for the two surveys. The serosurvey
protocol was developed through a consultative process and
sought to minimize disruption to the PCES. For example,
two separate electronic questionnaires for the PCES and
serosurvey were used. To avoid repeating questions, data
from the PCES questionnaire were shared with the serosurvey team. Additional questions not captured by the PCES
were asked in the serosurvey questionnaire after the PCES
team completed their questionnaire.
In anticipation of hesitancy toward blood collection, the
serosurvey team developed a sensitization plan at the provincial, district, and community levels in collaboration with
MoH district management teams aimed at communicating the
purpose and procedures of the serosurvey to key stakeholders in study communities. The plan was adapted from
previous household surveys that collected blood in the community and achieved good participation rates.12,14 A letter
from the MoH was issued to the provincial and district medical
ofﬁcers to inform staff about the serosurvey in their communities. Within each district, the district health management

FIGURE 1. CONSORT enrollment ﬂow diagram comparing post-campaign coverage evaluation survey (PCES) plus serosurvey clusters and
PCES-only clusters in Southern Province, Zambia.
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FIGURE 2. Lessons learned from nesting a serosurvey within a vaccination coverage survey. MoH = Ministry of Health.

teams implemented community sensitization based on
micro-plans developed for each study community. Typically,
the nurse in charge, the environmental health technician at
health facilities in the study communities, and a community
representative, such as a community health worker, conducted door-to-door sensitization at least 3 days before the
survey and made announcements on the local radio station.
They facilitated meetings between the ﬁeld team and the
local community leaders to introduce the serosurvey, and
community representatives accompanied the serosurvey
teams to all households during data collection, ensuring
continuity between the sensitization and serosurvey ﬁeld
activities.
Each serosurvey ﬁeld team comprised four data collectors
paired with two PCES data collectors. At least one of the four
serosurvey data collectors was a certiﬁed clinical staff trained
in collecting DBS and one of the two PCES data collectors was
the team leader. The serosurvey teams were trained for 5 days
in eliciting immunization history, reviewing household-based
immunization records, informed consent process, ﬁngerprick
blood collection, and DBS preparation. Collection of ﬁngerprick blood on DBS ﬁlter paper provided an advantage because it does not require staff with phlebotomy skills, cold
chain, or access to a centrifuge in the ﬁeld, which are common
obstacles to blood collection in the ﬁeld.15
Two separate ethical approvals were obtained for the
serosurvey and the PCES because serosurvey participants
were required to provide written informed consent. Ethical
approval for the serosurvey was obtained from Johns Hopkins
Bloomberg School of Public Health Institutional Review
Board, Macha Research Trust Ethics Review Committee, and
the Zambia National Health Research Regulatory Authority.
Enrollment of all household members, including those outside
the target age group for the PCES, increased the length of
interviews and moderately slowed data collection. On average, data collection took 2 days in a PCES-only cluster and
3 days in a paired PCES and serosurvey cluster.
Most challenges stemmed from the fact that two separate
electronic questionnaires were administered: one for the
PCES questions and the other for additional questions and
procedures relevant to the serosurvey (Figure 2). In addition,
the serosurvey was a research project and, therefore, required
additional ethical approvals, informed consent processes,
separate data collection tools, and linkage of household and
participant identiﬁcation numbers during data analysis to
PCES data. A more efﬁcient design would be to fully integrate

the serosurvey by adding blood collection and additional
questions to the PCES. This approach was not implemented
because of limited time in the planning phase, uncertainties
regarding the timeline and survey instruments, and the
concern expressed by the PCES leadership that adding
blood collection could increase refusals and induce a response bias for the main survey. The participation rates for
the PCES were higher in the serosurvey clusters than those
for PCES-only clusters, and individual refusals for blood
collection were low although some hesitancy was observed.
Future surveys need to weigh the risks of refusal and its
potential impact on representativeness against the efﬁciency, cost savings, and beneﬁts of fully integrating blood
collection into PCES activities.
By successfully conducting a serological survey within the
PCES in Southern Province, Zambia, we demonstrated the
feasibility of nesting a serosurvey in a health-related household survey. With appropriate statistical and logistical adaptations, serological surveys can be implemented as part of
other planned household surveys, providing a platform for
blood collection to measure antibodies to vaccine-preventable
and emerging infectious disease antigens while leveraging
existing surveillance systems and resources. Lessons learned
from this study provide guidance for implementation of future
nested serosurveys (Figure 2).
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